<p>Combined silencing of VEGF-A and angiopoietin-2, a more effective way to inhibit the Ishikawa endometrial cancer cell line</p>

Xiaofeng Xu, Yuhua Yan, Qingying Xun, Jiayu Shi, Xiangyi Kong, Jun Wu, Huaijun Zhou

Open source

DOI
10.2147/ott.s194064
Published
2019-02
Container
OncoTargets and Therapy
Publisher
Informa UK Limited
Open access
unknown

Credibility signals

serious concern Score 29/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.2147/ott.s194064,
  title = {\<p\>Combined silencing of VEGF-A and angiopoietin-2, a more effective way to inhibit the Ishikawa endometrial cancer cell line\</p\>},
  author = {Xiaofeng Xu and Yuhua Yan and Qingying Xun and Jiayu Shi and Xiangyi Kong and Jun Wu and Huaijun Zhou},
  year = {2019},
  journal = {OncoTargets and Therapy},
  doi = {10.2147/ott.s194064},
  url = {https://doi.org/10.2147/ott.s194064}
}

RIS

TY  - JOUR
TI  - <p>Combined silencing of VEGF-A and angiopoietin-2, a more effective way to inhibit the Ishikawa endometrial cancer cell line</p>
AU  - Xiaofeng Xu
AU  - Yuhua Yan
AU  - Qingying Xun
AU  - Jiayu Shi
AU  - Xiangyi Kong
AU  - Jun Wu
AU  - Huaijun Zhou
PY  - 2019
JO  - OncoTargets and Therapy
DO  - 10.2147/ott.s194064
UR  - https://doi.org/10.2147/ott.s194064
ER  - 

APA

Xu, X., Yan, Y., Xun, Q., Shi, J., Kong, X., Wu, J., & Zhou, H. (2019). <p>Combined silencing of VEGF-A and angiopoietin-2, a more effective way to inhibit the Ishikawa endometrial cancer cell line</p>. OncoTargets and Therapy. https://doi.org/10.2147/ott.s194064

Source records